methylene blue has been researched along with Genetic Predisposition in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C | 1 |
Liu, L; Lohman, RJ; Morris, M; O'Brien, TJ | 1 |
2 other study(ies) available for methylene blue and Genetic Predisposition
Article | Year |
---|---|
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Child; Cytochrome P-450 CYP2B6; Female; Genetic Predisposition to Disease; Humans; Ifosfamide; Male; Methylene Blue; Neuroprotective Agents; Osteosarcoma; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Outcome | 2018 |
Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studies.
Topics: Animals; Anticonvulsants; Coloring Agents; Diffusion; Disease Models, Animal; Drug Delivery Systems; Electroencephalography; Epilepsy; Female; Genetic Predisposition to Disease; Intralaminar Thalamic Nuclei; Methylene Blue; Microinjections; Rats; Rats, Mutant Strains; Reproducibility of Results; Stereotaxic Techniques; Thalamus; Ventral Thalamic Nuclei | 2005 |